Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$509,540,755
-$11,328,189 QoQ
Shares Held
3,251,281
-4.7% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#7
of 1,602 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $21,591,255,986 across 16 Drug Manufacturers - General names. NVS ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,590,218 | $5,505,645,627 | |
| 2 | ABBV |
AbbVie Inc.
|
19,925,232 | $5,013,985,374 | |
| 3 | AZN |
Astrazeneca PLC
|
16,511,727 | $3,130,953,667 | |
| 4 | JNJ |
Johnson & Johnson
|
10,086,602 | $2,561,694,303 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,548,585 | $2,511,993,169 | |
| 6 | NVO |
Novo Nordisk A S
|
13,041,109 | $625,190,761 | |
| 7 | NVS |
Novartis AG
This page
|
3,251,281 | $509,540,755 | |
| 8 | AMGN |
Amgen Inc
|
1,365,550 | $494,492,960 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $509,540,755 | 3,251,281 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $520,868,944 | 3,409,944 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $617,562,052 | 4,479,307 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $520,567,064 | 4,059,319 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $513,012,936 | 4,239,426 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $552,196,444 | 4,953,323 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $423,843,239 | 4,355,598 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $503,447,369 | 4,377,042 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $568,442,102 | 5,339,490 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $551,340,588 | 5,699,789 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $597,236,438 | 5,914,989 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $632,661,829 | 6,211,092 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $623,981,624 | 6,183,546 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $642,370,864 | 6,982,292 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $608,032,019 | 6,702,293 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $547,247,597 | 7,199,679 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $632,975,346 | 7,488,174 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $634,374,934 | 7,229,344 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $799,546,386 | 9,140,807 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $554,375,414 | 6,778,863 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $686,326,072 | 7,522,206 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $721,828,250 | 8,444,411 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $804,545,674 | 8,520,022 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $724,421,407 | 8,330,513 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $741,106,362 | 8,485,303 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $732,505,586 | 8,884,240 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||